DFX Intelligence

Andrew Bouldin

Managing Partnerat FCA Venture Management Group LLC· TN

As of 2026-09-30 · this person's identity; each section below carries its own date

Current roles: 6
Investments attributed: 5
Board seats: 3

Ask DFX about this View relationships Find contacts Investments Board seats

As of 2026-09-30 · this person's identity; each section below carries its own date

1 additional role or seat, 2 additional attributed investments, 2 verified contacts (2 professional url)

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

3 deals
12 months
3 investments attributed in the last 12 months; latest Branchlab Form D equity offering ($28.8M) on 20 May 2026.
A partner with a recent deal is actively writing cheques now.
Factfunding announcements and Form D naming the personFor Founders, co-investorsInvestments →
3 boards
seats on record
Sits on 3 boards on record, the latest Branchlab on 20 May 2026.
Board seats show where this partner holds governance, not only a cheque.
InferenceForm D directors and board-seat attributionsFor Founders, co-investorsBoard seats →

Relationship network

7 connected entities5 observed investment recordsinvestment records 2025 to 2026

From the roles sources name this person in, the investments a source attributes to them, and the boards and funds Form D names them on.

Some relationships on this record are counted rather than named here. They open with the full profile.

Click any name or line for the investment records and sources behind it. Line weight is investment records together; dashed lines are inferred.

Reading the network

Organization
Company

›How strength and recency are read

Venture relationships are not scored. Each line names its claim: a round led or joined, a board seat or a filing that names the firm, a listing on a portfolio page (dated by when DFX saw it, never by when the investment was made), a disclosed LP commitment, or a co-investor pair counted from observed participations. Observed means a named source says so; Derived means DFX counted it from observed rows; Inferred means a match that may be wrong.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

Ask DFX about this network

Which companies and boards is Andrew Bouldin connected to?

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Andrew Bouldin: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Andrew Bouldin

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Drawing the relationship network…

Roles

4 current, 0 past

FCA Venture Partners VII Management LLC Partner
Apr 1, 2021 to present · “Schedule A: Bouldin, Andrew, PARTNER, since 04/2021, ownership B, control person Y”
Fact Form ADV
FCA Health Innovations II Management LLC Partner
Oct 1, 2020 to present · “Schedule A: Bouldin, Andrew, PARTNER, since 10/2020, ownership B, control person Y”
Fact Form ADV
FCA Venture Management Group LLC Managing Partner
? to present · “team page: Andrew Bouldin / Managing Partner”
Fact Firm website

Investments attributed to this person

Company	Round	Investor	Attribution	Date	Source
Branchlab Inc.	board only	FCA Venture Partners VII Management LLC	strongly supported · board	May 20, 2026	Inference sec.gov
Branchlab Inc.	Form D equity offering · $28.8M	FCA Venture Partners	strongly supported · board	May 20, 2026	Inference sec.gov
Branchlab Inc.	Series A · $26.0M · Series A	FCA Venture Partners	confirmed	May 13, 2026	Fact prnewswire.com

Board seats and vehicles

3 boards, 0 vehicles

Branchlab Inc. Director May 20, 2026 Inference
Casechek, Inc. Director Sep 10, 2025 Inference
Gobiquity, Inc. Director Jun 12, 2025 Inference

Timeline

4 dated entries: events, attributed deals, board seats and role changes

May 20, 2026
Board seat at Branchlab Inc. (FCA Venture Partners VII Management LLC)
Board seat Inference Branchlab Inc. Form D
May 13, 2026
Series A in Branchlab Inc. (FCA Venture Partners)
Attributed investment Fact Branchlab Inc. Press release
Apr 1, 2021
Joined FCA Venture Partners VII Management LLC as Partner
Role began Fact FCA Venture Partners VII Management LLC Form ADV
Oct 1, 2020
Joined FCA Health Innovations II Management LLC as Partner
Role began Fact FCA Health Innovations II Management LLC Form ADV